| Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3 D Chendil, RS Ranga, D Meigooni, S Sathishkumar, MM Ahmed Oncogene 23 (8), 1599-1607, 2004 | 395 | 2004 |
| Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission … R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ... JAMA neurology 78 (8), 961-971, 2021 | 243 | 2021 |
| 18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases DN Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, V Bourakova, ... Brain 143 (11), 3477-3494, 2020 | 131 | 2020 |
| The role of amyloid PET in imaging neurodegenerative disorders: a review M Chapleau, L Iaccarino, D Soleimani-Meigooni, GD Rabinovici Journal of Nuclear Medicine 63 (Supplement 1), 13S-19S, 2022 | 125 | 2022 |
| Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ... Neurology 96 (5), e650-e661, 2021 | 108 | 2021 |
| Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab L VandeVrede, DM Gibbs, M Koestler, R La Joie, PA Ljubenkov, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 86 | 2020 |
| Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer’s disease A Strom, L Iaccarino, L Edwards, OH Lesman-Segev, ... Brain 145 (2), 713-728, 2022 | 68 | 2022 |
| Tau positron emission tomographic findings in a former US football player with pathologically confirmed chronic traumatic encephalopathy WG Mantyh, S Spina, A Lee, L Iaccarino, D Soleimani-Meigooni, E Tsoy, ... JAMA neurology 77 (4), 517-521, 2020 | 58 | 2020 |
| Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer’s disease JA Tanner, L Iaccarino, L Edwards, BM Asken, ML Gorno-Tempini, ... Brain 145 (12), 4489-4505, 2022 | 57 | 2022 |
| Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer’s Disease Continuum L Iaccarino, R La Joie, L Edwards, A Strom, DR Schonhaut, ... Cerebral Cortex 31 (1), 1-14, 2021 | 45 | 2021 |
| The impact of demographic, clinical, genetic, and imaging variables on tau PET status R Ossenkoppele, A Leuzy, H Cho, CH Sudre, O Strandberg, R Smith, ... European journal of nuclear medicine and molecular imaging 48, 2245-2258, 2021 | 44 | 2021 |
| Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females L Edwards, R La Joie, L Iaccarino, A Strom, SL Baker, KB Casaletto, ... Neurobiology of Aging 105, 86-98, 2021 | 40 | 2021 |
| Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) H Cho, NS Mundada, LG Apostolova, MC Carrillo, R Shankar, AN Amuiri, ... Alzheimer's & Dementia 19, S98-S114, 2023 | 33 | 2023 |
| Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment NS Mundada, JC Rojas, L Vandevrede, EH Thijssen, L Iaccarino, ... Alzheimer's Research & Therapy 15 (1), 157, 2023 | 23 | 2023 |
| The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort A Touroutoglou, Y Katsumi, M Brickhouse, A Zaitsev, R Eckbo, P Aisen, ... Alzheimer's & Dementia 19, S74-S88, 2023 | 20 | 2023 |
| Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts K Provost, L Iaccarino, DN Soleimani-Meigooni, S Baker, L Edwards, ... European journal of nuclear medicine and molecular imaging 48, 2259-2271, 2021 | 19 | 2021 |
| Plasma P-tau181 and P-tau217 in patients with traumatic encephalopathy syndrome with and without evidence of Alzheimer disease pathology BM Asken, JA Tanner, L VandeVrede, WG Mantyh, KB Casaletto, ... Neurology 99 (6), e594-e604, 2022 | 18 | 2022 |
| JC virus granule cell neuronopathy in the setting of chronic lymphopenia treated with recombinant interleukin-7 DN Soleimani-Meigooni, KE Schwetye, MR Angeles, CF Ryschkewitsch, ... Journal of neurovirology 23, 141-146, 2017 | 18 | 2017 |
| Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early‐onset Alzheimer's disease S Nemes, PE Logan, MK Manchella, NS Mundada, R La Joie, ... Alzheimer's & Dementia 19, S49-S63, 2023 | 16 | 2023 |
| Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection DB Hammers, A Eloyan, A Taurone, M Thangarajah, L Beckett, S Gao, ... Alzheimer's & Dementia 19, S8-S18, 2023 | 16 | 2023 |
